ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,949.17
      -0.60%
      US Tech 100
      20,270.40
      -1.07%
      Dow Jones
      43,750.86
      -0.47%
      Brent Oil
      71.75
      -0.64%
      Bitcoin
      87,308.61
      -0.04%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Moderna Inc (MRNA)

      7. Moderna Inc (MRNA) News

      Moderna Inc

      Moderna Inc (MRNA)

      NASDAQ
      39.77
      -2.37
      (-5.62%)
      Closed November 14 4:00PM
      Delayed by 15 minutes
      39.30
      -0.47
      (-1.18%)
      After Hours: 7:58PM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      MRNA News

      Official News Only

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      November 12 2024
      MRNA (-5.62%)

      Form 144 - Report of proposed sale of securities
      Edgar (US Regulatory)
      November 12 2024
      MRNA (-5.62%)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      Edgar (US Regulatory)
      November 07 2024
      MRNA (-5.62%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      November 07 2024
      MRNA (-5.62%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      October 08 2024
      MRNA (-5.62%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      October 04 2024
      MRNA (-5.62%)

      Form 3 - Initial statement of beneficial ownership of securities
      Edgar (US Regulatory)
      October 04 2024
      MRNA (-5.62%)

      MRNA Discussion

      View Posts
      axelvento axelvento 52 minutes ago
      RFK Jr. has built a reputation as a vaccine skeptic but has stopped short of adopting the “anti-vaxx” label attributed to him by critics. The former environmental lawyer has said his children are vaccinated and that he does not oppose safe vaccines.

      relax$
      👍️0
      axelvento axelvento 2 hours ago
      Kennedy has been one of the country’s most prominent anti-vaccine conspiracy theorists for years and has frequently spread falsehoods about the safety and efficacy of vaccines. Last week, Kennedy said he would “immediately” begin studying vaccine safety and efficacy but promised to not “take vaccines away from anybody.”
      👍️0
      Bountiful_Harvest Bountiful_Harvest 4 hours ago
      Shares of $MRNA and other hot shot stocks in full collapse on news of RFK joining the Trump admin

      👍️0
      spartex spartex 8 hours ago
      Big selling all of a sudden. Sub $40 now. 52 week low.

      Appears that Trump will nominate Rfk Jr. to Health and Human Services Admin.

      https://www.politico.com/news/2024/11/14/robert-f-kennedy-jr-trump-hhs-secretary-pick-00188617
      👍️0
      axelvento axelvento 24 hours ago
      next-
      https://www.theguardian.com/society/2024/oct/23/doctors-trial-worlds-first-vaccine-against-vomiting-bug-norovirus
      👍️ 3 🔜 1
      Vexari Vexari 2 days ago
      The majority shareholder of Moderna is?

      When you are suffering

      They are profiting
      👇️ 1 🗑️ 1 🚽 1 🤪 1 🧻 1
      axelvento axelvento 3 days ago
      https://www.biospace.com/job-trends/biospace-announces-2025-best-places-to-work-in-biopharma
      👋 1 👍 1
      axelvento axelvento 6 days ago
      Jpmorgan Chase & Co ownership in MRNA / Moderna, Inc.
      On November 8, 2024 - Jpmorgan Chase & Co filed a 13F-HR form disclosing ownership of 2,227,044 shares of Moderna, Inc. (US:MRNA) valued at $148,833,351 USD as of September 30, 2024. The entity filed a previous 13F-HR on August 12, 2024 disclosing 1,756,708 shares of Moderna, Inc.. This represents a change in shares of 26.77% during the quarter. The current value of the position is $104,292,471 USD.

      https://fintel.io/so/us/mrna/jpmorgan-chase-
      👍 2
      axelvento axelvento 6 days ago
      https://www.acsh.org/news/2024/11/07/dont-be-afraid-mrna-vaccines-49111
      👍️ 3 🤙 1
      axelvento axelvento 6 days ago
      Moderna Buys Norwood Campus for $400M

      https://bankerandtradesman.com/moderna-buys-norwood-campus-for-400m/#:~:text=Lab%20developer%20Alexandria%20Real%20Estate,core%20properties%20in%20Greater%20Boston.
      👍️ 3 😀 1
      axelvento axelvento 1 week ago
      Moderna (MRNA) Q3 2024 Earnings Call Transcript

      https://www.fool.com/earnings/call-transcripts/2024/11/07/moderna-mrna-q3-2024-earnings-call-transcript/
      👍️ 4 ✌️ 1
      EarningsCentral EarningsCentral 1 week ago
      👍️0
      axelvento axelvento 1 week ago
      MRNA is set to report third-quarter 2024 earnings on Nov. 7, before the opening bell. The Zacks Consensus Estimate for sales and earnings is pegged at $1.25 billion and a loss of $1.91 per share, respectively
      👍️0
      axelvento axelvento 3 weeks ago
      Merck and Moderna Initiate Phase 3 Trial Evaluating Adjuvant V940 (mRNA-4157) in Combination with KEYTRUDA® (pembrolizumab) After Neoadjuvant KEYTRUDA and Chemotherapy in Patients With Certain Types of Non-Small Cell Lung Cancer (NSCLC)

      https://investors.modernatx.com/news/news-details/2024/Merck-and-Moderna-Initiate-Phase-3-Trial-Evaluating-Adjuvant-V940-mRNA-4157-in-Combination-with-KEYTRUDA-pembrolizumab-After-Neoadjuvant-KEYTRUDA-and-Chemotherapy-in-Patients-With-Certain-Types-of-Non-Small-Cell-Lung-Cancer-NSCLC/default.aspx


      huge news$
      👍️ 1 🤑 1
      axelvento axelvento 3 weeks ago
      https://www.investing.com/news/company-news/piper-sandler-maintains-overweight-rating-on-moderna-stock-93CH-3680972
      👋 1 👍️ 2
      axelvento axelvento 3 weeks ago
      20B market cap, 10B in cash, high potential pipeline in 4 therapeutic areas!
      👍️ 2 💪 1
      axelvento axelvento 3 weeks ago
      Moderna has a whopping 33 million short share interest, but daily volume now a paper-thin 3.7 million

      "Highest shorted stock on S&P500"
      👍️ 1 🤣 1 ☝️ 1
      axelvento axelvento 3 weeks ago
      MRNA December 6th Options Begin Trading

      https://www.nasdaq.com/articles/mrna-december-6th-options-begin-trading
      👍️0
      axelvento axelvento 3 weeks ago
      Moderna’s norovirus vaccine enters Phase III trials in the UK
      The firm hopes to file marketing applications in 2026 to have the vaccine approved by health regulators.

      https://www.clinicaltrialsarena.com/news/modernas-norovirus-vaccine-enters-phase-iii-trials-in-the-uk/
      👍️ 2 🤙 1
      Vexari Vexari 3 weeks ago
      Depends

      On the road

      That they're on
      👎️ 1 🗑️ 1 🚽 1 🧻 1 0️⃣ 1
      Vexari Vexari 3 weeks ago
      All that is marketed

      Is fear based
      🌬️ 1 🎃 1 👎️ 1 🕳️ 1 🗑️ 1
      gapole gapole 4 weeks ago
      looks like meltdown here. where is the bad news? $53.54
      👍️0
      Monksdream Monksdream 4 weeks ago
      MRNA new 52. Week low
      👍️0
      axelvento axelvento 4 weeks ago
      Moderna stock touches 52-week low. bouncer
      👍️0
      axelvento axelvento 4 weeks ago
      https://www.kcl.ac.uk/news/mrna-cancer-vaccine-potential-advanced-stage-cancer-patients-in-phase-1-trial
      👍️ 1 ✌️ 1
      jondoeuk jondoeuk 4 weeks ago
      I couldn't find a PR or the poster.
      👍️0
      Vexari Vexari 1 month ago
      Unraveling all the Lies of the Covid-19

      Psychological Operation
      👎️ 2 🗑️ 1 😎 1 🤥 1 🧻 1 0️⃣ 1
      axelvento axelvento 1 month ago
      $MRNA We are tackling cancer on an individual basis where we can take samples from each patient, understand their cancer, and design a therapy specifically for them

      https://www.fastcompany.com/91202048/the-mrna-advantage
      👍️ 1 🫨 1 ☝️ 1
      tmonkey tmonkey 1 month ago
      this one near a bottom-im in------tmonkey
      👍️0
      axelvento axelvento 1 month ago
      https://www.globenewswire.com/news-release/2024/10/04/2958235/0/en/Global-mRNA-Cancer-Vaccine-Clinical-Trial-FDA-Approval-Market-Size-Future-Opportunity-Companies-Insight.html

      $MRNA
      👍️ 1 🤑 1
      axelvento axelvento 1 month ago
      Join us on Nov 8, as we, alongside
      moderna_
      , share promising data on anti-GPC3 in vivo CAR-M therapy for HCC. We'll also present TIP poster for the Ph1 study of anti-HER2 CAR-Monocytes targeting solid tumors.

      https://ir.carismatx.com/news-releases/news-release-details/carisma-therapeutics-announces-upcoming-presentations-sitc-2024
      👍️ 1 😃 1
      axelvento axelvento 1 month ago
      back to the 23 November lows bounce spot watching either way to see if holds or breaks.
      👍️0
      axelvento axelvento 1 month ago
      We have put the mescaline to make you feel better-have a good trip$MRNA
      👍️ 2 😀 1
      axelvento axelvento 1 month ago
      With post hoc analysis....
      👍️ 2 🤑 1
      Vexari Vexari 1 month ago
      What's in this dose of Pivotal

      How does it affect the immune system

      Why not question what is being announced

      Instead of grabbing onto it

      Hook line and sinker
      👎️ 1 🗑️ 1 🤪 1 🧻 1 0️⃣ 1
      axelvento axelvento 1 month ago
      Moderna Announces First Participant Dosed in Pivotal Phase 3 Trial of Investigational mRNA Norovirus Vaccine, mRNA-1403

      https://investors.modernatx.com/news/news-details/2024/Moderna-Announces-First-Participant-Dosed-in-Pivotal-Phase-3-Trial-of-Investigational-mRNA-Norovirus-Vaccine-mRNA-1403/default.aspx
      👍️ 1 ✌️ 1
      axelvento axelvento 1 month ago
      Moderna and Cenra Healthcare Enter Joint Agreement to Promote Moderna’s mRNA Respiratory Vaccine Portfolio in Taiwan, Including COVID-19 Vaccines

      https://investors.modernatx.com/news/news-details/2024/Moderna-and-Cenra-Healthcare-Enter-Joint-Agreement-to-Promote-Modernas-mRNA-Respiratory-Vaccine-Portfolio-in-Taiwan-Including-COVID-19-Vaccines/default.aspx
      👍️0
      axelvento axelvento 2 months ago
      Multiple key late-stage readouts are on the way as well. Moderna should report phase 3 results for cytomegalovirus (CMV) vaccine mRNA-1647 as early as year-end. It's also on track to begin generating data later this year from pivotal studies of mRNA-3705 and mRNA-3927 targeting metabolic disorders methylmalonic acidemia and propionic acidemia, respectively.
      👍️ 2 😝 1
      axelvento axelvento 2 months ago
      First cancer vaccine may enter the market in 2025. Always keep that in mind
      👍️ 1 ✌️ 1
      axelvento axelvento 2 months ago
      Mr Justice Meade concluded one of the European Moderna patents, labelled EP565, was “invalid”.

      But the judge said a different patent, called EP949, was “valid” and was infringed by Pfizer and BioNTech.

      https://finance.yahoo.com/news/covid-19-vaccine-patent-legal-123139810.html

      full stop$$$$$$$
      👋 1 👍️ 1
      Vexari Vexari 2 months ago
      What happened to the NIH director

      So many have yet

      To be disclosed
      🎃 1 👎️ 1 🕳️ 1 🗑️ 1 🧻 1
      axelvento axelvento 2 months ago
      https://www.marketbeat.com/instant-alerts/nasdaq-mrna-sec-filing-2024-09-22/
      👍️0
      axelvento axelvento 2 months ago
      With Pfizer hitting a stumbling block, Moderna’s COVID-19/influenza vaccine, mRNA-1083, could be the first such combination vaccine to reach the market. In June, the company posted results from a Phase III trial that showed mRNA-1083 produced a strong immune response against both COVID-19 and influenza. In releasing the results, Moderna also became the first and, due to Pfizer/BioNTech’s struggles, only company to date to post positive Phase III results for a combination COVID-19/influenza vaccine.

      https://www.biospace.com/drug-development/5-late-stage-mrna-vaccines-to-watch
      👍️ 2 ✌️ 1
      DewDiligence DewDiligence 2 months ago
      That's a clcikbait article, IMO. NVO's working with a small company who has some expertise in RNA does not make NOVO a competitor of MRNA.
      👍️0
      axelvento axelvento 2 months ago
      Novo Nordisk Just Took a $530 Million Step Onto Moderna's Turf. Here's What It Means for Both Stocks

      https://www.fool.com/investing/2024/09/19/novo-nordisk-just-took-a-530-million-step-onto-mod/

      $RELAX
      👍️0
      axelvento axelvento 2 months ago
      Buy the Fear, Sell the Greed$$$$$$
      👍️0
      Vexari Vexari 2 months ago
      That is the question

      Why does the NIH own half

      Of all MRNA injections
      👎️ 1 🗑️ 1 🤪 1 🧻 1 0️⃣ 1
      axelvento axelvento 2 months ago
      I do not know, what do you think? "It has to bounce back"
      👍️0
      axelvento axelvento 2 months ago
      Moderna was getting too big, too fast. "The size of our late-stage pipeline combined with the challenge of launching products means we must now focus on delivering these 10 products to patients, slow down the pace of new R&D investment, and build our commercial business," said chief executive officer Stéphane Bancel.
      This is after -- just last year -- forecasting the launch of as many as 15 new products over the next five years.

      THE WRITING IS ON THE WALL

      https://www.fool.com/investing/2024/09/14/after-moderna-shocking-news-is-stock-a-buy-or-sell/
      👍️ 1 😀 1
      Monksdream Monksdream 2 months ago
      MRNA how much lower can it go
      😎 1

      Your Recent History

      NASDAQ
      MRNA
      Moderna
      BIT
      B
      Bastogi
      USOTC
      GAERF
      Grupo Aeroportuario del ... (PK)
      NASDAQ
      PRTC
      PureTech Health
      BIT
      NSCIT0013325
      Republic of France
      BIT
      NSCIT4392246
      IBRD
      BIT
      P1YKV6
      NLBNPIT1YKV6 20991231 33...
      BIT
      P1W9O7
      NLBNPIT1W9O7 20991231 4....
      BIT
      P1ZF14
      NLBNPIT1ZF14 20991231 10...
      Delayed Upgrade Clock